Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo

Ecem Sevim; Salma Siddique; Madhavi Latha S. Chalasani; Susan Chyou; William D. Shipman; Orla O’Shea; Joanna Harp; Oral Alpan; Stéphane Zuily; Theresa T. Lu; Doruk Erkan

doi:10.3899/jrheum.220049

Research ArticleSystemic Lupus Erythematosus

Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo

Ecem Sevim, Salma Siddique, Madhavi Latha S. Chalasani, Susan Chyou, William D. Shipman, Orla O’Shea, Joanna Harp, Oral Alpan, Stéphane Zuily, Theresa T. Lu and Doruk Erkan

The Journal of Rheumatology September 2022, 49 (9) 1026-1030; DOI: https://doi.org/10.3899/jrheum.220049

Ecem Sevim

1E. Sevim, MD, Department of Rheumatology, Hospital for Special Surgery, New York, and Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ecem Sevim
For correspondence: ecemsevim@gmail.com

Salma Siddique

2S. Siddique, DO, Pediatric Rheumatology, Hospital for Special Surgery, New York, New York, now with Nemours Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Madhavi Latha S. Chalasani

3M.L.S. Chalasani, PhD, T.T. Lu, MD, PhD, Pediatric Rheumatology, Hospital for Special Surgery, Autoimmunity and Inflammation Program, Hospital for Special Surgery Research Institute, and Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Susan Chyou

4S. Chyou, BA, O. O’Shea, MS, Autoimmunity and Inflammation Program, Hospital for Special Surgery Research Institute, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William D. Shipman

5W.D. Shipman, BS, Autoimmunity and Inflammation Program, Hospital for Special Surgery Research Institute, and Weill Cornell Tri-Institutional MD-PhD Program, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Orla O’Shea

4S. Chyou, BA, O. O’Shea, MS, Autoimmunity and Inflammation Program, Hospital for Special Surgery Research Institute, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joanna Harp

6J. Harp, MD, Department of Dermatology, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Oral Alpan

7O. Alpan, MD, O&O Alpan, LLC, Fairfax, Virginia, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stéphane Zuily

8S. Zuily, MD, MPH, PhD, CHRU de Nancy, Vascular Medicine Division and Regional Competence Center For Rare Vascular And Systemic Autoimmune Diseases, and Inserm U1116 at Lorraine University, Nancy, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Theresa T. Lu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Doruk Erkan

9D. Erkan, MD, MPH, Department of Rheumatology, Hospital for Special Surgery, and Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery and Weill Cornell Medicine, New York, NY, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
References
PDF
eLetters

PreviousNext

Data supplements

Data Supplement

220049DataSuppl.pdf

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 49, Issue 9

1 Sep 2022

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo

Ecem Sevim, Salma Siddique, Madhavi Latha S. Chalasani, Susan Chyou, William D. Shipman, Orla O’Shea, Joanna Harp, Oral Alpan, Stéphane Zuily, Theresa T. Lu, Doruk Erkan

The Journal of Rheumatology Sep 2022, 49 (9) 1026-1030; DOI: 10.3899/jrheum.220049

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo

Ecem Sevim, Salma Siddique, Madhavi Latha S. Chalasani, Susan Chyou, William D. Shipman, Orla O’Shea, Joanna Harp, Oral Alpan, Stéphane Zuily, Theresa T. Lu, Doruk Erkan

The Journal of Rheumatology Sep 2022, 49 (9) 1026-1030; DOI: 10.3899/jrheum.220049

Share This Article: